dc.creator |
Nahar, Muna S. |
|
dc.creator |
Kim, Jung H. |
|
dc.creator |
Sartor, Maureen A. |
|
dc.creator |
Dolinoy, Dana C. |
|
dc.date |
2014-05-21T18:02:38Z |
|
dc.date |
WITHHELD_13_MONTHS |
|
dc.date |
2014-05-21T18:02:38Z |
|
dc.date |
2014-04 |
|
dc.date.accessioned |
2022-05-19T13:30:42Z |
|
dc.date.available |
2022-05-19T13:30:42Z |
|
dc.identifier |
Nahar, Muna S.; Kim, Jung H.; Sartor, Maureen A.; Dolinoy, Dana C. (2014). "Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver." Environmental and Molecular Mutagenesis 55(3): 184-195. |
|
dc.identifier |
0893-6692 |
|
dc.identifier |
1098-2280 |
|
dc.identifier |
http://hdl.handle.net/2027.42/106679 |
|
dc.identifier |
10.1002/em.21823 |
|
dc.identifier |
Environmental and Molecular Mutagenesis |
|
dc.identifier |
Sengupta S, Bolin JM, Ruotti V, Nguyen BK, Thomson JA, Elwell AL, Stewart R. 2011. Single read and paired end mRNA‐Seq Illumina libraries from 10 nanograms total RNA. J Vis Exp: e3340. |
|
dc.identifier |
Kundakovic M, Champagne FA. 2011. Epigenetic perspective on the developmental effects of bisphenol A. Brain Behav Immun 25: 1084 – 1093. |
|
dc.identifier |
Kyriakis JM, Avruch J. 2001. Mammalian mitogen‐activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807 – 869. |
|
dc.identifier |
McCarver DG, Hines RN. 2002. The ontogeny of human drug‐metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther 300: 361 – 366. |
|
dc.identifier |
Molina‐Molina JM, Amaya E, Grimaldi M, Saenz JM, Real M, Fernandez MF, Balaguer P, Olea N. 2013. In vitro study on the agonistic and antagonistic activities of bisphenol‐S and other bisphenol‐A congeners and derivatives via nuclear receptors. Toxicol Appl Pharmacol 272: 127 – 136. |
|
dc.identifier |
Naciff JM, Khambatta ZS, Reichling TD, Carr GJ, Tiesman JP, Singleton DW, Khan SA, Daston GP. 2010. The genomic response of Ishikawa cells to bisphenol A exposure is dose‐ and time‐dependent. Toxicology 270: 137 – 149. |
|
dc.identifier |
Nahar MS, Liao C, Kannan K, Dolinoy DC. 2012. Fetal liver bisphenol A concentrations and biotransformation gene expression reveal variable exposure and altered capacity for metabolism in humans. J Biochem Mol Toxicol 27: 116 – 123. |
|
dc.identifier |
O'Shaughnessy PJ, Monteiro A, Bhattacharya S, Fraser MJ, Fowler PA. 2013. Steroidogenic enzyme expression in the human fetal liver and potential role in the endocrinology of pregnancy. Mol Hum Reprod 19: 177 – 187. |
|
dc.identifier |
Omiecinski CJ, Aicher L, Swenson L. 1994. Developmental expression of human microsomal epoxide hydrolase. J Pharmacol Exp Ther 269: 417 – 423. |
|
dc.identifier |
Pfeiffer E, Metzler M. 2004. Effect of bisphenol A on drug metabolising enzymes in rat hepatic microsomes and precision‐cut rat liver slices. Arch Toxicol 78: 369 – 377. |
|
dc.identifier |
Rubin BS. 2011. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 127: 27 – 34. |
|
dc.identifier |
Saghir SA, Khan SA, McCoy AT. 2012. Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies. Crit Rev Toxicol 42: 323 – 357. |
|
dc.identifier |
Schonfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. 2002. Parent bisphenol A accumulation in the human maternal‐fetal‐placental unit. Environ Health Perspect 110: 703 – 707. |
|
dc.identifier |
Smith M, Hopkinson DA, Harris H. 1971. Developmental changes and polymorphism in human alcohol dehydrogenase. Ann Hum Genet 34: 251 – 271. |
|
dc.identifier |
Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3. |
|
dc.identifier |
Strange RC, Howie AF, Hume R, Matharoo B, Bell J, Hiley C, Jones P, Beckett GJ. 1989. The development expression of alpha‐, mu‐ and pi‐class glutathione S ‐transferases in human liver. Biochim Biophys Acta 993: 186 – 190. |
|
dc.identifier |
Suganuma T, Workman JL. 2012. MAP kinases and histone modification. J Mol Cell Biol 4: 348 – 350. |
|
dc.identifier |
Timens W, Kamps WA. 1997. Hemopoiesis in human fetal and embryonic liver. Microsc Res Tech 39: 387 – 397. |
|
dc.identifier |
Vogel C, Marcotte EM. 2012. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13: 227 – 232. |
|
dc.identifier |
Wang H, Ping J, Peng RX, Yue J, Xia XY, Li QX, Kong R, Hong JY. 2008. Changes of multiple biotransformation phase I and phase II enzyme activities in human fetal adrenals during fetal development. Acta Pharmacol Sin 29: 231 – 238. |
|
dc.identifier |
Watanabe H, Adachi R, Kusui K, Hirayama A, Kasahara T, Suzuki K. 2003. Bisphenol A significantly enhances the neutrophilic differentiation of promyelocytic HL‐60 cells. Int Immunopharmacol 3: 1601 – 1608. |
|
dc.identifier |
Watson CS, Jeng YJ, Guptarak J. 2011. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways. J Steroid Biochem Mol Biol 127: 44 – 50. |
|
dc.identifier |
Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, Watson CS, Zoeller RT, Belcher SM. 2007. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24: 178 – 198. |
|
dc.identifier |
Yordy JS, Muise‐Helmericks RC. 2000. Signal transduction and the Ets family of transcription factors. Oncogene 19: 6503 – 6513. |
|
dc.identifier |
Alcorn J, McNamara PJ. 2003. Pharmacokinetics in the newborn. Adv Drug Deliv Rev 55: 667 – 686. |
|
dc.identifier |
Allegaert K, van den Anker JN, Naulaers G, de Hoon J. 2007. Determinants of drug metabolism in early neonatal life. Curr Clin Pharmacol 2: 23 – 29. |
|
dc.identifier |
Allegaert K, Verbesselt R, Naulaers G, van den Anker JN, Rayyan M, Debeer A, de Hoon J. 2008. Developmental pharmacology: neonates are not just small adults. Acta Clin Belg 63: 16 – 24. |
|
dc.identifier |
Anderson OS, Nahar MS, Faulk C, Jones TR, Liao C, Kannan K, Weinhouse C, Rozek LS, Dolinoy DC. 2012. Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A. Environ Mol Mutagen 53: 334 – 342. |
|
dc.identifier |
Balakrishnan B, Henare K, Thorstensen EB, Ponnampalam AP, Mitchell MD. 2010. Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 202: 393 e391 – e397. |
|
dc.identifier |
Bassuk AG, Leiden JM. 1995. A direct physical association between ETS and AP‐1 transcription factors in normal human T cells. Immunity 3: 223 – 237. |
|
dc.identifier |
Benjamini Y, Hochberg Y. 1995. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Series B Stat Methodol 57: 289 – 300. |
|
dc.identifier |
Bromer JG, Zhou Y, Taylor MB, Doherty L, Taylor HS. 2010. Bisphenol‐A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J 24: 2273 – 2280. |
|
dc.identifier |
Buterin T, Koch C, Naegeli H. 2006. Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 27: 1567 – 1578. |
|
dc.identifier |
Caldwell J, Gardner I, Swales N. 1995. An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion. Toxicol Pathol 23: 102 – 114. |
|
dc.identifier |
Cao XL, Zhang J, Goodyer CG, Hayward S, Cooke GM, Curran IH. 2012. Bisphenol A in human placental and fetal liver tissues collected from Greater Montreal area (Quebec) during 1998–2008. Chemosphere 89: 505 – 511. |
|
dc.identifier |
Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933 – 2942. |
|
dc.identifier |
Chepelev NL, Enikanolaiye MI, Chepelev LL, Almohaisen A, Chen Q, Scoggan KA, Coughlan MC, Cao XL, Jin X, Willmore WG. 2013. Bisphenol A activates the Nrf1/2‐antioxidant response element pathway in HEK 293 cells. Chem Res Toxicol 26: 498 – 506. |
|
dc.identifier |
Coolen MW, Statham AL, Gardiner‐Garden M, Clark SJ. 2007. Genomic profiling of CpG methylation and allelic specificity using quantitative high‐throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 35: e119. |
|
dc.identifier |
Duanmu Z, Weckle A, Koukouritaki SB, Hines RN, Falany JL, Falany CN, Kocarek TA, Runge‐Morris M. 2006. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre‐ and postnatal human liver. J Pharmacol Exp Ther 316: 1310 – 1317. |
|
dc.identifier |
Hanet N, Lancon A, Delmas D, Jannin B, Chagnon MC, Cherkaoui‐Malki M, Latruffe N, Artur Y, Heydel JM. 2008. Effects of endocrine disruptors on genes associated with 17beta‐estradiol metabolism and excretion. Steroids 73: 1242 – 1251. |
|
dc.identifier |
Hanioka N, Jinno H, Tanaka‐Kagawa T, Nishimura T, Ando M. 2000. Interaction of bisphenol A with rat hepatic cytochrome P450 enzymes. Chemosphere 41: 973 – 978. |
|
dc.identifier |
Hanioka N, Takeda Y, Tanaka‐Kagawa T, Hayashi K, Jinno H, Narimatsu S. 2008. Interaction of bisphenol A with human UDP‐glucuronosyltransferase 1A6 enzyme. Environ Toxicol 23: 407 – 412. |
|
dc.identifier |
Hines RN. 2007. Ontogeny of human hepatic cytochromes P450. J Biochem Mol Toxicol 21: 169 – 175. |
|
dc.identifier |
Hines RN. 2008. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118: 250 – 267. |
|
dc.identifier |
Hines RN, McCarver DG. 2002. The ontogeny of human drug‐metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 300: 355 – 360. |
|
dc.identifier |
Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. 2006. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66: 5624 – 5632. |
|
dc.identifier |
Hogart A, Lichtenberg J, Ajay SS, Anderson S, Margulies EH, Bodine DM. 2012. Genome‐wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites. Genome Res 22: 1407 – 1418. |
|
dc.identifier |
Hollenhorst PC, McIntosh LP, Graves BJ. 2011. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80: 437 – 471. |
|
dc.identifier |
Jeong H. 2010. Altered drug metabolism during pregnancy: Hormonal regulation of drug‐metabolizing enzymes. Expert Opin Drug Metab Toxicol 6: 689 – 699. |
|
dc.identifier |
Jiménez‐Díaz I, Zafra‐Gómez A, Ballesteros O, Navea N, Navalón A, Fernández MF, Olea N, Vílchez JL. 2010. Determination of Bisphenol A and its chlorinated derivatives in placental tissue samples by liquid chromatography‐tandem mass spectrometry. J Chromatogr B 878: 3363 – 3369. |
|
dc.identifier |
Kennedy M. 2008. Hormonal regulation of hepatic drug‐metabolizing enzyme activity during adolescence. Clin Pharmacol Ther 84: 662 – 673. |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/117384 |
|
dc.description |
Peer Reviewed |
|
dc.description |
http://deepblue.lib.umich.edu/bitstream/2027.42/106679/1/em21823.pdf |
|
dc.format |
application/pdf |
|
dc.publisher |
Wiley Periodicals, Inc. |
|
dc.rights |
IndexNoFollow |
|
dc.subject |
Transcription Factor |
|
dc.subject |
Xenobiotic Metabolism |
|
dc.subject |
Liver |
|
dc.subject |
DNA Methylation |
|
dc.subject |
Bisphenol A |
|
dc.subject |
Biological Chemistry |
|
dc.subject |
Genetics |
|
dc.subject |
Molecular, Cellular and Developmental Biology |
|
dc.subject |
Health Sciences |
|
dc.subject |
Science |
|
dc.title |
Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver |
|
dc.type |
Article |
|